Loading...
All Posts By
Blog Author

Eric Horler, MBA, MS

Company

Going Beyond Biomarkers to Predict Immunotherapy Effectiveness

Advanced imaging is one technology that could offer a real solution in predicting both the beneficial treatment response and the harmful side effects of immunotherapy treatments. At AIQ Solutions, we are working on technology that combines PET/CT scan data with advanced algorithms to better determine which patients will have a desirable response to immunotherapy.

Posted on 
Jul 16, 2020
  by
Eric Horler, MBA, MS
Read More

Per the US FDA, AIQ technology is indicated for use in the identification, quantification, and evaluation of Regions of Interest (ROIs) from digital medical images, including PET and CT. Any other applications of AIQ technology are for research purposes only.